Bindarit

CAS No. 130641-38-2

Bindarit( AF 2838 )

Catalog No. M11224 CAS No. 130641-38-2

Bindarit exhibits selective inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 68 In Stock
5MG 113 In Stock
10MG 177 In Stock
25MG 300 In Stock
50MG 447 In Stock
100MG 642 In Stock
500MG 1314 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bindarit
  • Note
    Research use only, not for human use.
  • Brief Description
    Bindarit exhibits selective inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.
  • Description
    Bindarit exhibits selective inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.(In Vitro):Bindarit (10-300 μM; 48 hours) at 100 μM and 300 μM significantly inhibits platelet derived growth factor-BB (PDGF-BB)-induced rat VSMCs proliferation by 27% and 42%, respectively.(In Vivo):Bindarit (50 mg/kg; oral administration; every day; for 4 months, 6 months, 8 months; NZB/W F1 female mice) delays the onset of proteinuria and significantly protects from renal function impairment. Bindarit completely prevents monocyte chemoattractant protein (MCP-1) up-regulation.
  • In Vitro
    Cell Viability AssayCell Line:VSMC cells Concentration:10 μM, 30 μM, 100 μM, 300 μM Incubation Time:48 hours Result:Inhibited PDGF-BB-induced rat VSMCs proliferation.
  • In Vivo
    Animal Model:NZB/W F1 female mice ( two months of age)Dosage:50 mg/kg Administration:Oral administration; every day; for 4 months, 6 months, 8 months Result:Delayed the onset of proteinuria and significantly protected from renal function impairment.
  • Synonyms
    AF 2838
  • Pathway
    Autophagy
  • Target
    CCR
  • Recptor
    MCP-1/CCL2| MCP-2/CCL8| MCP-3/CCL7
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    130641-38-2
  • Formula Weight
    324.37
  • Molecular Formula
    C19H20N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:65 mg/mL (200.38 mM); Ethanol:65 mg/mL (200.38 mM); Water:<1 mg/mL (<1 mM)
  • SMILES
    CC(C)(OCC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3)C(O)=O
  • Chemical Name
    2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zoja C, et al. Kidney Int, 1998, 53(3), 726-734.
molnova catalog
related products
  • Plozalizumab

    Plozalizumab (MLN-1202) is a humanized, selective, and potent anti-CCR2 antibody with antitumor activity, used in the study of malignant melanoma.

  • CCR3 antagonist 1

    CCR3 antagonist 1 is a potent CCR3 antagonist used in researching inflammatory and immunologic diseases.

  • Bindarit

    Bindarit exhibits selective inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.